• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Prenetics Global Limited (Amendment)

    2/7/23 9:26:04 PM ET
    $PRE
    Blank Checks
    Finance
    Get the next $PRE alert in real time by email
    SC 13G/A 1 13G.htm Schedule 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1    )*

     

     

    PRENETICS GLOBAL LIMITED

    (Name of Issuer)

    Class A ordinary shares

    (Title of Class of Securities)

    G72245106

    (CUSIP Number)

    December 30, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    (X) Rule 13d-1(b)

    Rule 13d-1(c)

    Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


     

    CUSIP No. G72245106  

     

      1.   

    Names of Reporting Persons.

     

    EASTSPRING INVESTMENTS (SINGAPORE) LIMITED

      2.  

    Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)            (b)           

      3.  

    SEC Use Only

     

      4.  

    Citizenship or Place of Organization

     

    SG

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With:

       5.    

    Sole Voting Power

     

    12,660,138

       6.   

    Shared Voting Power

     

       7.   

    Sole Dispositive Power

     

    12,660,138

       8.   

    Shared Dispositive Power

     

      9.  

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    12,660,138

    10.  

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

    11.  

    Percent of Class Represented by Amount in Row (9)

     

    9.9%

    12.  

    Type of Reporting Person (See Instructions)

     

    IA


    CUSIP No. G72245106  

     

      1.   

    Names of Reporting Persons.

     

    PRUDENTIAL HONG KONG LIMITED

      2.  

    Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)            (b)           

      3.  

    SEC Use Only

     

      4.  

    Citizenship or Place of Organization

     

    HK

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With:

       5.    

    Sole Voting Power

     

       6.   

    Shared Voting Power

     

       7.   

    Sole Dispositive Power

     

       8.   

    Shared Dispositive Power

     

      9.  

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    12,660,138

    10.  

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

    11.  

    Percent of Class Represented by Amount in Row (9)

     

    9.9%

    12.  

    Type of Reporting Person (See Instructions)

     

    IC



    Item 1.

     

      (a) Name of Issuer

    PRENETICS GLOBAL LIMITED

     

      (b) Address of Issuer's Principal Executive Offices

    Unit 701-706, K11 Atelier, 728 King's Road, Quarry Bay, Hong Kong.

    Item 2.

     

      (a) Name of Person Filing

    EASTSPRING INVESTMENTS (SINGAPORE) LIMITED

     

      (b) Address of Principal Business Office or, if none, Residence

    10 Marina Boulevard, #32-01, Marina Bay Financial Centre, Singapore 018983

     

      (c) Citizenship

    SG

     

      (d) Title of Class of Securities

    Class A ordinary Shares

     

      (e) CUSIP Number

    G72245106


    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is:

     

    (a)      A Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
    (b)      A Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)      An insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)      An investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)   X    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
    (f)      An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
    (g)      A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
    (h)      A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)      A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)      A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
    (k)      A group, in accordance with §240.13d-1(b)(1)(ii)(K).

    Item 4. Ownership.

     

      (a) Amount beneficially owned:

    See Item 9 on the cover page(s) hereto.

     

      (b) Percent of class:

    See Item 11 on the cover page(s) hereto.

     

      (c) Number of shares as to which such person has:

     

      (i) Sole power to vote or to direct the vote:

    See Item 5 on the cover page(s) hereto.

     

      (ii) Shared power to vote or to direct the vote:

    See Item 6 on the cover page(s) hereto.

     

      (iii) Sole power to dispose or to direct the disposition of:

    See Item 7 on the cover page(s) hereto.


      (iv) Shared power to dispose or to direct the disposition of:

    See Item 8 on the cover page(s) hereto.

    Item 5. Ownership of 5% or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [].

    Item 6. Ownership of More than 5 Percent on Behalf of Another Person

    Not Applicable

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    Not Applicable

    Item 8. Identification and Classification of Members of the Group

    Not Applicable

    Item 9. Notice of Dissolution of Group

    Not Applicable

    Item 10. Certifications

    By signing below each signatory certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

     

    Date: 2023-01-16

     

          EASTSPRING INVESTMENTS (SINGAPORE) LIMITED
         
         

     

        By:  
        Name:   Lim Siew May
        Title:   Assistant Director - Global Shareholding Reporting

     

          PRUDENTIAL HONG KONG LIMITED
         
         

     

        By:  
        Name:   Dicky Lam
        Title:   Chief Financial Officer

     

     


    EXHIBIT INDEX

     

    Exhibit

      

    Description of Exhibit

    99.1    Joint Filing Agreement
    Get the next $PRE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PRE

    DatePrice TargetRatingAnalyst
    2/11/2026$36.00Buy
    Roth Capital
    1/18/2023$7.00Overweight
    Cantor Fitzgerald
    7/12/2022Buy
    Citigroup
    More analyst ratings

    $PRE
    SEC Filings

    View All

    SEC Form 6-K filed by Prenetics Global Limited

    6-K - Prenetics Global Ltd (0001876431) (Filer)

    1/6/26 8:03:45 AM ET
    $PRE
    Blank Checks
    Finance

    SEC Form 6-K filed by Prenetics Global Limited

    6-K - Prenetics Global Ltd (0001876431) (Filer)

    1/5/26 8:20:41 AM ET
    $PRE
    Blank Checks
    Finance

    SEC Form 6-K filed by Prenetics Global Limited

    6-K - Prenetics Global Ltd (0001876431) (Filer)

    12/30/25 8:22:21 AM ET
    $PRE
    Blank Checks
    Finance

    $PRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on Prenetics Group Ltd. with a new price target

    Roth Capital initiated coverage of Prenetics Group Ltd. with a rating of Buy and set a new price target of $36.00

    2/11/26 7:52:37 AM ET
    $PRE
    Blank Checks
    Finance

    Cantor Fitzgerald initiated coverage on Prenetics Group Ltd. with a new price target

    Cantor Fitzgerald initiated coverage of Prenetics Group Ltd. with a rating of Overweight and set a new price target of $7.00

    1/18/23 7:56:45 AM ET
    $PRE
    Blank Checks
    Finance

    Citigroup initiated coverage on Prenetics Group Ltd.

    Citigroup initiated coverage of Prenetics Group Ltd. with a rating of Buy

    7/12/22 11:48:35 AM ET
    $PRE
    Blank Checks
    Finance

    $PRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call

    NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced it will release financial results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Wednesday, February 18, 2026. The Company will also hold its earnings conference call the same day at 10:00 a.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts. Date:Wednesday, February 18, 2026Time:10:00 a.m. Eastern TimeDial-in:1-877-425-9470International Dial-in:1-201-389-0878

    2/11/26 8:00:00 AM ET
    $PRE
    Blank Checks
    Finance

    Prenetics Reinforces Strategic Focus on IM8, Divests Europa Business For Up to $13 Million

    Company Continues Portfolio Optimization on the Heels of Successful $72 million ACT Genomics sale Company Maintains Strong Balance Sheet with over $70 million in Cash and Cash Equivalents, 510 BTC and Zero Debt, representing approximately $118 million in Total Liquidity CHARLOTTE, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced that it has completed the sale of its 3PL distribution business operated by its subsidiary, Europa Sports Partners. The all-stock transaction is valued at up to $13 million, subject to the achieve

    1/6/26 8:00:00 AM ET
    $PRE
    Blank Checks
    Finance

    Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% Participation

    CHARLOTTE, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced an update to its previously announced voluntary warrant exchange program. Updated Participation and Impact In connection with the Company's prior financing round in October 2025, 2,722,642 Class A ordinary shares were issued, with one Class A warrant and one Class B warrant issued for each such Class A ordinary share, for a total of 5,445,284 warrants. As of the date of this announcement, the Company has entered into exchange agreements covering 4,720,832 of the

    1/5/26 8:00:00 AM ET
    $PRE
    Blank Checks
    Finance

    $PRE
    Leadership Updates

    Live Leadership Updates

    View All

    Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board

    -  Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy's ~$40B Bitcoin holdings and Metaplanet's meteoric treasury transformation -  Following strategic divestiture, Prenetics leverages strengthened $117M balance sheet to execute comprehensive Bitcoin strategy with board-approved majority allocation, institutional financing partnerships, and alpha-generating initiatives. CHARLOTTE, N.C., June 18, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE), a leading health sciences company, today announced it has become the first healthcare company to establish a Bitcoin treasury, completing a $20 million Bitcoin purchase of 187.42 BTC at an averag

    6/18/25 8:45:00 AM ET
    $PRE
    Blank Checks
    Finance

    Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors

    LOS ANGELES, July 01, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company, welcomes Kathryn M. Henry and David Vanderveen as independent directors to the Company's Board of Directors. "We are excited to welcome Kathryn and David to Prenetics' Board of Directors at this pivotal juncture," said Danny Yeung, CEO of Prenetics. "Their unparalleled expertise in consumer and health sectors, combined with their proven leadership in driving global expansion and operational excellence, will significantly enhance shareholder value as we expand into consumer health and wellness." "I am thrilled to join Prenetics at such a p

    7/1/24 8:30:00 AM ET
    $PRE
    Blank Checks
    Finance

    Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

    (From left: Dr. Ghada Alsaleh, Sonia Pawelczyk, Danny Yeung, Dr. James L. Green, Ahmed Alfandi, Dr. Tara Ruttley, Wasim Ahmed, Dr. Hilde Stenuit, Dr. Camille Alleyne at the MOU signing ceremony in Dubai, UAE Space Agency) Initial research project is with NDORMS, Botnar Research Institute, University of Oxford, focusing on accelerated aging in spaceDr. James L. Green, former Chief Scientist of NASA and Dr. Tara Ruttley, former Associate Chief Scientist of NASA to join Prenetics Scientific Advisory BoardInaugural research cube scheduled to be sent on-board SpaceX to the ISS in Q4 of 2024 DUBAI, United Arab Emirates, Feb. 09, 2024 (GLOBE NEWSWIRE) -- UAE Space Agency – Prenetics Global Li

    2/9/24 9:25:22 AM ET
    $PRE
    Blank Checks
    Finance

    $PRE
    Financials

    Live finance-specific insights

    View All

    Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call

    NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced it will release financial results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Wednesday, February 18, 2026. The Company will also hold its earnings conference call the same day at 10:00 a.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts. Date:Wednesday, February 18, 2026Time:10:00 a.m. Eastern TimeDial-in:1-877-425-9470International Dial-in:1-201-389-0878

    2/11/26 8:00:00 AM ET
    $PRE
    Blank Checks
    Finance

    Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History

    Total Revenue Surges 568% YoY to $23.6 million; IM8 Monthly Revenue Hits Record US$9 million in October; Bitcoin Treasury Reaches 387 BTC (~$40M); IM8 Projects $180 - $200M FY 2026 Revenue, $25M Monthly Revenue or $300M ARR by Year End 2026 IM8 Delivers 60% Gross Margin, 3.9 Months Payback Period, Demonstrating Strong Unit Economics Company to Host Earnings Call Today at 8:30am ET, Releases Inaugural Quarterly Shareholder Letter CHARLOTTE, N.C., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced third quarter 2025 financial

    11/10/25 7:24:27 AM ET
    $EXOD
    $PRE
    Finance: Consumer Services
    Finance
    Blank Checks

    Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call

    CHARLOTTE, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company, today announced it will release financial results for the third quarter 2025 ended September 30, 2025 before market open on Monday, November 10, 2025. The Company will also hold its first ever earnings conference call the same day at 8:30 a.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts. Date:Monday, November 10, 2025Time:8:30 a.m. Eastern TimeDial-in:1-844-425-9470International Dial-in:201-298-0878WebcastPRE Conference Call An audio replay of the webcast will

    11/4/25 4:05:00 PM ET
    $PRE
    Blank Checks
    Finance

    $PRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Prenetics Global Limited

    SC 13G/A - Prenetics Global Ltd (0001876431) (Subject)

    11/14/24 12:30:15 PM ET
    $PRE
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Prenetics Global Limited (Amendment)

    SC 13G/A - Prenetics Global Ltd (0001876431) (Subject)

    2/5/24 6:05:14 AM ET
    $PRE
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Prenetics Global Limited (Amendment)

    SC 13G/A - Prenetics Global Ltd (0001876431) (Subject)

    11/27/23 6:05:43 AM ET
    $PRE
    Blank Checks
    Finance